Stock Comparison
ARGX vs REGN
argenx NV ADR and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$80.55B
P/E (TTM)
32.7
19.4
Forward P/E
30.4
17.1
Price/Sales
10.0
5.2
Price/Book
6.4
2.5
EV/EBITDA
27.6
13.1
Dividend Yield
—
0.45%
Profitability
Net Margin
30.44%
29.65%
Operating Margin
27.34%
24.32%
Return on Equity
23.60%
14.00%
Return on Assets
11.60%
6.53%
Growth (YoY)
Revenue Growth
59.30%
16.70%
Earnings Growth
95.20%
-4.50%
Price & Risk
Beta
-0.0
0.2
52-Week High
$939.68
$810.12
52-Week Low
$652.43
$553.38
Analyst Target
$1,085.78
$833.54
Compare ARGX and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.